Payer access   the challenges
Upcoming SlideShare
Loading in...5
×
 

Payer access the challenges

on

  • 501 views

With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…

With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted…

Statistics

Views

Total Views
501
Views on SlideShare
501
Embed Views
0

Actions

Likes
0
Downloads
12
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Payer access   the challenges Payer access the challenges Presentation Transcript

  • PARIOFORMA With increased incidences of reimbursement rejections by payers and a growing usage of pricing and reimbursement tools market access is becoming increasingly restricted… In many markets, the process for gaining reimbursement is characterized by a health technology assessment (HTA) approach whereby payer organizations evaluate new medical technologies on the basis of their clinical value, cost- effectiveness and other health economic factors. Consequently, manufacturers of pharma products now face unique informational and evidentiary demands to demonstrate comparative value. Of all factors contributing to product success, payer access is considered the most critical – therefore, the sooner this is at the table, the more likely successful pricing and reimbursement strategies are to be realized. Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom www.parioforma.com
  • Case Study:A global pharmaceutical manufacturer contacted us to undertake an early environmentmapping exercise in selected emerging markets – with particular focus on evolving HTA PARIOFORMArequirementsKey findings: Changing decision-makers – physician power is eroding. Multiple buyers – all with different priorities and differing views about your product, adding complexity to the purchasing process. Rise of new influencers – payer organisations and health technology assessment agencies are becoming gatekeepers. Pricing pressure – intense pressure to contain costs and work within pre-defined budgets. Stakeholder fragmentation – a broadened range of market access stakeholders. Emerging markets are complex and evolving environments – political and economic transition has resulted in many changes in the healthcare environment of these countries. Abbreviations: CEA – Cost Effectiveness Analysis; CUA – Cost Utility Analysis; BIA – Budget Impact Analysis Parioforma Ltd – 55 Princes Gate – London SW7 2PN – United Kingdom www.parioforma.com
  • Plan ahead and start early in the product lifecycle: Every market is different – payer profiling & environment mapping is key to helping manufacturers understand the complex reimbursement, coverage and decision making landscape. PARIOFORMA Studies need not be in-depth, early directional work can guide strategy development, help build early value messages and save time and money by ensuring that any future large global study asks the right questions and is not overly complicated.We can help you:We specialise in payer research and environment mapping - quickly and affordably. With a network ofover 500 payer specialists worldwide - our scope is global and we have the resources and experienceto tailor our services to meet your needs… For further information, or to discuss your Payer & Market Access requirements, contact us now on +44 (0) 207 225 3538 or email Charles Rowlands at: charles.rowlands@parioforma.com